| Name | Volagidemab |
|---|
| Description | Volagidemab is an antagonistic glucagon receptor (GCGR) monoclonal antibody (mAb). Volagidemab can be used in the research of type 1 diabetes (T1D)[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Volagidemab (5 mg/kg,皮下注射) 在四氧嘧啶诱导的糖尿病小鼠中抑制 1 型糖尿病表型[2]。 Animal Model: Alloxan-induced diabetic mice [2] Dosage: 5 mg/kg Administration: Subcutaneous injection (s.c.) Result: Reduced phosphorylated CREB protein and PEPCK protein expression to nondiabetic levels. |
| References |
| No Any Chemical & Physical Properties |